文献速递产科母胎医学

病理诊断的胎盘植入与再次妊娠中的出血性并发症

Pathologically Diagnosed Placenta Accreta and Hemorrhagic Morbidity in a Subsequent Pregnancy.
PubMed 文献 · Obstet Gynecol · 2017-01-01

回顾性队列研究纳入2007至2015年在本学术中心首孕病理诊断胎盘植入且未行子宫切除、随后再次妊娠分娩的339例患者,其中39例(11.5%)再次分娩。首孕无并发症者再次妊娠均未发生严重并发症,而首孕有任何并发症者中6/21(29%)再次妊娠发生严重并发症(P=.02)。作者结论认为再次妊娠严重出血风险取决于临床背景,既往因出血或胎盘残留治疗且病理证实植入者需做好大出血准备。

要点

  • 339例病理诊断胎盘植入未行子宫切除者中39例(11.5%)再次妊娠分娩。
  • 首孕无并发症者再次妊娠无严重并发症,首孕有并发症者6/21(29%)再次妊娠发生严重并发症(P=.02)。
  • 作者认为既往妊娠合并出血或胎盘残留治疗且病理证实植入者,再次妊娠需做好大出血准备。

核心结论

  • 既往病理诊断胎盘植入后再次妊娠发生严重出血性并发症的风险取决于临床背景。
  • 作者认为,任何既往妊娠合并出血或因胎盘残留治疗且病理证实胎盘植入者,再次妊娠时应做好大出血准备。

研究设计与样本

  • 2007至2015年在本学术中心开展的回溯性队列研究。
  • 对象为首孕病理诊断胎盘植入、未行子宫切除且随后再次妊娠分娩的患者。
  • 339例病理诊断胎盘植入未行子宫切除者中39例(11.5%)再次妊娠分娩。
  • 再次分娩结局分为轻度、重度或无并发症。

主要发现

  • 39例再次妊娠分娩者中14例(36%)首孕胎盘植入为临床识别。
  • 39例中21例(54%)首孕发生并发症,其中16例(76%)为轻度、5例(24%)为重度。
  • 首孕无并发症者再次妊娠均无重度并发症,而首孕有任何并发症者中6/21(29%)再次妊娠发生重度并发症(P=.02)。
  • 首孕有并发症者中25%在随访时获临床或病理胎盘植入诊断,首孕无并发症者为0(P=.05)。

关键数值与推荐

  • 轻度并发症包括阴道分娩估计出血量500-1,500 cc、剖宫产估计出血量1,000-1,500 cc、输注1至3单位红细胞及小型手术操作。
  • 重度并发症包括估计出血量大于1,500 cc、输注大于3单位红细胞、子宫动脉栓塞、非计划剖腹探查或子宫切除。

临床怎么用

  • 作者认为,任何既往妊娠合并出血或因胎盘残留治疗且病理证实胎盘植入者,再次妊娠时应做好大出血准备。
  • 作者结论指出,既往病理诊断胎盘植入后再次妊娠的严重出血性并发症风险取决于临床背景。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify the relationship between pathologically diagnosed placenta accreta and risk of major morbidity in a subsequent pregnancy. METHODS: We conducted a retrospective cohort study of patients with pathologically diagnosed placenta accreta in an index pregnancy who returned with a subsequent pregnancy at our academic center from 2007 to 2015. Subsequent delivery outcomes included minor, major, or no morbidity. Minor morbidity included estimated blood loss 500-1,500 cc for vaginal and 1,000-1,500 cc for cesarean delivery, transfusion of one to three units of red cells, and minor surgical procedures. Major morbidity included estimated blood loss greater than 1,500 cc, transfusion of greater than three units of red cells, uterine artery embolization, unplanned laparotomy, or hysterectomy. RESULTS: Three hundred thirty-nine patients with pathologically diagnosed accreta did not undergo hysterectomy, and 39 (11.5%) of these returned for subsequent delivery. Of these, 14 (36%) had accretas that had been identified clinically in the index pregnancy. Twenty-one (54%) experienced morbidity in the index pregnancy, 16 of these (76%) minor and five (24%) major. Of patients without morbidity in the first pregnancy, none experienced major morbidity in a subsequent pregnancy, whereas 6 of 21 (29%) with any index morbidity had a subsequent major morbid outcome (P=.02). Of those with a morbid index delivery, 25% had either a clinical or pathologic accreta diagnosis at follow-up compared with none of those who index accreta was nonmorbid (P=.05). CONCLUSION: Risk for major hemorrhagic morbidity after a prior pathologically diagnosed accreta depends on the clinical context. Preparation for major blood loss is indicated after any prior pregnancy complicated by hemorrhage or treatment of retained placenta with a pathologic accreta.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Roeca C, Little SE, Carusi DA, et al. Pathologically Diagnosed Placenta Accreta and Hemorrhagic Morbidity in a Subsequent Pregnancy. Obstet Gynecol. 2017. PMID: 28079779. doi:10.1097/AOG.0000000000001843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。